chr2-166073371-T-C
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001165963.4(SCN1A):c.251A>G(p.Tyr84Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN1A | NM_001165963.4 | MANE Select | c.251A>G | p.Tyr84Cys | missense | Exon 4 of 29 | NP_001159435.1 | ||
| SCN1A | NM_001353961.2 | c.-2175A>G | 5_prime_UTR_premature_start_codon_gain | Exon 3 of 28 | NP_001340890.1 | ||||
| SCN1A | NM_001202435.3 | c.251A>G | p.Tyr84Cys | missense | Exon 3 of 28 | NP_001189364.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | MANE Select | c.251A>G | p.Tyr84Cys | missense | Exon 4 of 29 | ENSP00000501589.1 | ||
| SCN1A | ENST00000303395.9 | TSL:5 | c.251A>G | p.Tyr84Cys | missense | Exon 3 of 28 | ENSP00000303540.4 | ||
| SCN1A | ENST00000375405.7 | TSL:5 | c.251A>G | p.Tyr84Cys | missense | Exon 1 of 26 | ENSP00000364554.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Severe myoclonic epilepsy in infancy Pathogenic:1Other:1
The variant is not observed in the gnomAD v4.0.0 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.85 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 1.00 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000068520 /PMID: 17347258). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (PMID: 36964972). A different missense change at the same codon (p.Tyr84His) has been reported to be associated with SCN1A related disorder (PMID: 36964972). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Developmental and epileptic encephalopathy Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with cysteine at codon 84 of the SCN1A protein (p.Tyr84Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. This variant has been reported in individual(s) with Dravet syndrome (PMID: 17347258, 23195492, 22050978). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 68520). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function. For these reasons, this variant has been classified as Pathogenic.
Severe myoclonic epilepsy in infancy;C1858673:Generalized epilepsy with febrile seizures plus, type 2;C1864987:Migraine, familial hemiplegic, 3 Pathogenic:1
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (Lek et al., 2016); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This substitution is predicted to be within the N-terminal cytoplasmic domain; This variant is associated with the following publications: (PMID: 19589774, 21248271, 32090326, 17347258, 23195492, 29933521, 31031587)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at